News and Trends 30 May 2023 Pancreatic cancer microbiome discovery holds treatment hope …secure diverse IR candidates, the project involves comprehensive genomic and functional analysis of disease-associated microbiomes and bacteriophages. Additionally, the project aims to elucidate the mode of action (MoA) of IR-related… May 30, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2019 The 10 Biotech Companies in London to Keep an Eye on in 2019 …in the city, these are the 10 biotech companies in London you need to know. Founded in 2015, Orchard Therapeutics is developing multiple gene therapy candidates to treat rare genetic… June 10, 2019 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Opinion 12 Dec 2022 Artificial intelligence: a new era in rare genetic disease diagnosis …candidate variants in undiagnosed genetic disorders and better inform healthcare professionals. By quickly identifying the most promising candidate variants for interpretation, AI-driven tools are revolutionary, supporting experts in making fast,… December 12, 2022 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
In Depth 14 May 2025 The stem cell race for Parkinson’s disease: Recent studies show significant promise …from the U.S. Food and Drug Administration (FDA) to progress the candidate in January 2025. This came after the candidate, which is made up of immature brain cells called dopaminergic… May 14, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2023 Can stem cell treatment repair damaged knees? …the hyperbaric oxygen chamber is to encourage stem cells to produce capillaries and blood vessels. Is stem cell therapy a worthy candidate to target knee arthritis? Meanwhile, knee arthritis (osteoarthritis)… August 15, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jan 2025 ITM-11 succeeds in phase 3: The first big win for radiopharma? …more and more investment and candidates are showing great promise, the field still awaits its first big win. The COMPETE trial is the first to show that a targeted radiopharmaceutical… January 28, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2017 Genfit Gets €180M Cash Injection to Bring its Pipeline to Market Elafibranor, Genfit’s lead candidate, will continue its march towards the market with the added boost of massive financial support. Genfit is a leader in the development of diagnostic tools and… October 17, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 27 Jun 2025 Psychedelics sans side effects: neuroplastogens gain ground …in neuropsychiatry. With its lead candidate in the Investigational New Drug (IND)-enabling stage, the Washington-based startup hopes to head to the clinic to treat depression and PTSD soon. As about… June 27, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 19 Apr 2017 UPDATE: Verona sets terms & dials back its IPO goal to a still-hefty €75M …its lead candidate RPL554 for the treatment of chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). The company also announced the dosing of the first patient for its new… April 19, 2017 - 3 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Aug 2023 Six Toronto-based biotech companies to watch this year …like Deep Genomics having developed a portfolio of candidates, some of which are being evaluated as therapies for central nervous system (CNS)-related disorders, the city’s research and development sector is… August 17, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 5 Sep 2017 The Next Generation of Genetic Medicine: A Review of Epigenetics …that patient stratification is not an option. A German company, 4SC, has taken heed of such findings, combining its lead candidate resminostat with Bayer’s kinase inhibitor, Nexavar (sorafenib). In January,… September 5, 2017 - 9 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 6 Sep 2022 IRLAB’s partner Ipsen starts mesdopetam clinical studies …Ipsen for the development and commercialization of mesdopetam. IRLAB has generated all its drug candidates and continues to discover innovative drug candidates for the treatment of CNS disorders through its… September 6, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email